Wang ZM - Search Results

1

BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.

Tao YM, Huang JL, Zeng S, Zhang S, Fan XG, Wang ZM, Yang HX, Yuan XH, Wang P, Wu F, Luo J, Zeng DY, Shen H. Tao YM, et al. Among authors: wang p, wang zm. Hepatology. 2013 Jun;57(6):2326-37. doi: 10.1002/hep.26268. Hepatology. 2013. PMID: 23325674

2

Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma.

Fan XG, Peng XN, Huang Y, Yakoob J, Wang ZM, Chen YP. Fan XG, et al. Among authors: wang zm. Clin Infect Dis. 2002 Dec 15;35(12):1555-7. doi: 10.1086/344770. Epub 2002 Dec 3. Clin Infect Dis. 2002. PMID: 12471577

3

Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.

Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH. Gao YW, et al. Among authors: wang zm. Hepatogastroenterology. 2008 Mar-Apr;55(82-83):345-50. Hepatogastroenterology. 2008. PMID: 18613363

4

The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma.

Zhou L, Huang Y, Li J, Wang Z. Zhou L, et al. Med Oncol. 2010 Jun;27(2):255-61. doi: 10.1007/s12032-009-9201-4. Epub 2009 Mar 20. Med Oncol. 2010. PMID: 19301157

5

Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma.

Ouyang M, Wu W, Zou Y, Zhou J, Wang Z, Wan X. Ouyang M, et al. Surg Oncol. 2010 Jun;19(2):82-7. doi: 10.1016/j.suronc.2009.03.010. Epub 2009 May 15. Surg Oncol. 2010. PMID: 19447030 Review.

6

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Li N, Long Y, Fan X, Liu H, Li C, Chen L, Wang Z. Li N, et al. J Exp Clin Cancer Res. 2009 Aug 28;28(1):122. doi: 10.1186/1756-9966-28-122. J Exp Clin Cancer Res. 2009. PMID: 19715608 Free PMC article.

7

Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.

Ye K, Wang Z, Zhang G, Liang S. Ye K, et al. J Invest Surg. 2010 Jun;23(3):163-9. doi: 10.3109/08941939.2010.481010. J Invest Surg. 2010. PMID: 20590388 Free article.

8

Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.

Zhang G, Liu T, Wang Z. Zhang G, et al. J Invest Surg. 2012 Apr;25(2):93-9. doi: 10.3109/08941939.2011.606875. Epub 2011 Sep 26. J Invest Surg. 2012. PMID: 21942217 Free article.

9

High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Jiang W, Wang Z, Li X, Fan X, Duan Y. Jiang W, et al. Pathol Oncol Res. 2012 Apr;18(2):293-8. doi: 10.1007/s12253-011-9442-3. Epub 2011 Sep 7. Pathol Oncol Res. 2012. PMID: 21953322 Free article.

10

Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.

Jiang W, Wang Z, Li X, Li J, Huang Y, Fan X, Duan Y. Jiang W, et al. Dig Dis Sci. 2012 Jan;57(1):92-8. doi: 10.1007/s10620-011-1944-z. Epub 2011 Oct 26. Dig Dis Sci. 2012. PMID: 22038506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,697 results

Search Page

Filters